New Study Questions the Safety of Caspase Inhibitors for the Treatment of Liver Disease (IMAGE)

Elsevier Health Sciences

New Study Questions the Safety of Caspase Inhibitors for the Treatment of Liver Disease

Caption

Inhibition of caspases by ZVAD switched TNF/ActD-induced apoptosis to necrosis.

Credit

<i>The American Journal of Pathology</i>

Usage Restrictions

None.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.